Headlines:
Tag: Study
Customized Case Study Papers: Buy Them From Expert Writers

Customized Case Study Papers: Buy Them From Expert Writers

September 14, 2018 Algemeen

Customized Case Study Papers: Buy Them From Expert Writers Custom Case Study Papers They take the time to learn the actual situation, learn previous cases with similarity to ...

Lees verder
Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park

Britannia Pharmaceuticals Ltd: Phase 3 TOLEDO Study Shows Apomorphine Infusion Provides Effective Relief of Persistent Motor Fluctuations in Park

August 4, 2018 Economie

LONDON, August 3, 2018 /PRNewswire/ -- Britannia Pharmaceuticals Ltd has announced publication of the results of the double-blind phase of the TOLEDO study in Lancet ...

Lees verder
Adlai Nortye announces the publication of the Biomarker Analysis From BERIL-1, the Buparlisib study in HNSCC

Adlai Nortye announces the publication of the Biomarker Analysis From BERIL-1, the Buparlisib study in HNSCC

July 30, 2018 Economie

HANGZHOU, China, July 30, 2018 /PRNewswire/ -- Adlai Nortye Corporation, a leading biotech company in China, today announced a biomarker analysis publication by the ...

Lees verder
Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

Study Shows Intensive Blood Pressure Control Reduces Risk Of Mild Cognitive Impairment (MCI) And The Combined Risk Of MCI And Dementia

July 29, 2018 Economie

Plus: - Genomic Analysis of Alzheimer's Study May Enable a Precision Medicine Approach CHICAGO, July 25, 2018 /PRNewswire/ -- Significant reductions in the risk of mild ...

Lees verder
Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile

Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile

July 26, 2018 Economie

TAIPEI, Taiwan, July 26, 2018 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announced today that it has successfully completed a Phase 1 multiple ...

Lees verder
Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males

Pivotal Study Reveals Effectiveness of Blood Tests in Screening for Sleep Apnea in Adult Males

June 19, 2018 Economie

Published findings show initial testing for three specific biomarkers may provide superior results over standard screening methods BREA, California, June 19, 2018 /PRNewswire/ ...

Lees verder
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia

European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia

June 16, 2018 Economie

STOCKHOLM, June 16, 2018 /PRNewswire/ -- Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical ...

Lees verder
Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

June 2, 2018 Economie

POMEZIA, Italy, June 1, 2018 /PRNewswire/ -- Menarini Ricerche (Menarini Group) will present at ASCO Annual Meeting 2018 the study design of CD205-Shuttle, a multicenter ...

Lees verder
Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look 'Beyond the visible'

Galderma Global Study Reveals True Burden of Rosacea and Encourages Healthcare Professionals to Look 'Beyond the visible'

June 1, 2018 Economie

LAUSANNE, Switzerland, June 1, 2018 /PRNewswire/ -- Galderma today released the findings of a global survey highlighting the need for dermatologists and doctors to proactively ...

Lees verder
Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate

May 18, 2018 Economie

NOVATO, California, TOKYO and LONDON, May 17, 2018 /PRNewswire/ -- Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients ...

Lees verder
Nieuwe berichten
BizPress.nl